Veterinary Medicines

FATROXIMIN, ενδομαστική αλοιφή

Authorised
  • Rifaximin
Download as PDF

Product identification

Medicine name:
FATROXIMIN, ενδομαστική αλοιφή
Active substance:
  • Rifaximin
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Rifaximin
    0.10
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51XX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 65434/14-09-2012/K-0036502
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 12/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."